IDH突变型低级别胶质瘤患者的癫痫发作
基于人群的130例成人IDH突变型WHO 2或3级星形细胞瘤和少突胶质细胞瘤队列,评估手术前后癫痫负荷。星形细胞瘤54例(79.4%)、少突胶质细胞瘤45例(72.6%)术前有癫痫史;术后12个月无癫痫发作分别为51/67(76.1%)和47/62(75.8%)。多变量分析显示较低切除程度(OR 0.98;95%CI 0.97-1.00,p=0.01)和岛叶肿瘤位置(OR 5.02;95%CI 1.01-24.87,p=0.048)与术后1年内癫痫发作相关。
要点
- 星形细胞瘤54例(79.4%)、少突胶质细胞瘤45例(72.6%)术前有癫痫史。
- 术后12个月无癫痫发作:星形细胞瘤51/67(76.1%),少突胶质细胞瘤47/62(75.8%)。
- 较低切除程度和岛叶肿瘤位置与术后1年内癫痫发作相关。
核心结论
- 结果与非分子定义的低级别胶质瘤数据一致,大部分患者术后1年无癫痫发作。
- 星形细胞瘤中切除程度越高癫痫结局越好,但少突胶质细胞瘤中无此关联。
研究设计与样本
- 基于人群的队列研究,纳入130例成人IDH突变型WHO 2或3级星形细胞瘤和少突胶质细胞瘤患者。
主要发现
- 术前有癫痫史:星形细胞瘤54例(79.4%),少突胶质细胞瘤45例(72.6%)。
- 术后12个月无癫痫发作:星形细胞瘤51/67(76.1%),少突胶质细胞瘤47/62(75.8%)。
- 全队列多变量logistic回归:较低切除程度(OR 0.98;95%CI 0.97-1.00,p=0.01)和岛叶肿瘤位置(OR 5.02;95%CI 1.01-24.87,p=0.048)与术后1年内癫痫发作相关。
- 星形细胞瘤亚组:切除程度与术后癫痫发作相关(OR 0.98;95%CI 0.96-0.99,p<0.01);少突胶质细胞瘤亚组无此关联(p=0.34)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Most patients with Lower Grade Gliomas (LGG) present with epileptic seizures. Since the advent of molecular diagnostics, more homogenous sub-entities have emerged, including the isocitrate dehydrogenase-mutated (IDH-mutated) astrocytomas and 1p19q-codeleted oligodendrogliomas. We aimed to describe the occurrence of seizures in patients with molecularly defined LGG pre- and postoperatively and to analyze factors affecting seizure status postoperatively. METHODS: A population-based cohort of 130 adult patients with IDH-mutated WHO grade 2 or 3 astrocytomas and oligodendrogliomas was assessed pertaining to seizure burden before and after surgery. RESULTS: Fifty-four (79.4%) patients with astrocytoma and 45 (72.6%) patients with oligodendroglioma had a history of seizures before surgery. At 12 months postoperatively, 51/67 (76.1%) patients with astrocytoma and 47/62 (75.8%) patients with oligodendrogliomas were seizure free. In a multivariable logistic regression analysis, lower extent of resection (EOR) (OR 0.98; 95% CI 0.97-1.00, p = 0.01) and insular tumor location (OR 5.02; 95% CI 1.01-24.87, p = 0.048) were associated with presence of seizures within 1 year postoperatively in the entire LGG cohort. In sub-entities, EOR was in a similar manner associated with seizures postoperatively in astrocytomas (OR 0.98; 95% CI 0.96-0.99, p < 0.01) but not in oligodendrogliomas (p = 0.34). CONCLUSION: Our results are well in line with data published for non-molecularly defined LGG with a large proportion of patients being seizure free at 1 year postoperative. Better seizure outcome was observed with increased EOR in astrocytomas, but this association was absent in oligodendrogliomas.
引用
- Carstam L, Rydén I, Jakola AS, et al. Seizures in patients with IDH-mutated lower grade gliomas. J Neurooncol. 2022. PMID: 36258151. doi:10.1007/s11060-022-04158-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。